Nimbolide Induces Cell Apoptosis via Mediating ER Stress‐Regulated Apoptotic Signaling in Human Oral Squamous Cell Carcinoma

ABSTRACT Human oral squamous cell carcinoma (OSCC) poses a significant health challenge in Asia, with current therapeutic strategies failing to improve the survival rates for OSCC patients sufficiently. To elucidate the effects of Nimbolide on OSCC cell proliferation and apoptosis, we performed a se...

Full description

Saved in:
Bibliographic Details
Published inEnvironmental toxicology Vol. 40; no. 2; pp. 347 - 356
Main Authors Peng, Bou‐Yue, Wu, Chia‐Yu, Lee, Chia‐Jung, Chang, Tsung‐Ming, Tsao, Ya‐Ting, Liu, Ju‐Fang
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.02.2025
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:ABSTRACT Human oral squamous cell carcinoma (OSCC) poses a significant health challenge in Asia, with current therapeutic strategies failing to improve the survival rates for OSCC patients sufficiently. To elucidate the effects of Nimbolide on OSCC cell proliferation and apoptosis, we performed a series of experiments, including cell proliferation assays, annexin V/PI assays, and cell cycle analysis. We further investigated nimbolide's role in modulating endoplasmic reticulum (ER) stress, reactive oxygen species (ROS) production, and mitochondrial dysfunction using flow cytometry. Additionally, Western blotting was used to detect apoptosis‐related protein expression. Our findings reveal that nimbolide exerts its anti‐proliferative effects on OSCC cells by inducing apoptosis. The nimbolide increased intracellular ROS levels and acceleration of cellular calcium accumulation, respectively promoting endoplasmic reticulum stress and cancer cell apoptosis. Furthermore, nimbolide activates the caspase cascade by altering the mitochondrial membrane potential and apoptotic protein expression, thereby inhibiting the viability of tumor cells. Our data show that Nimbolide suppresses tumor growth through the induction of ROS production, ER stress, and mitochondrial dysfunction, resulting in apoptosis in OSCC cells. Overall, our study highlights nimbolide as a potential natural compound for OSCC therapy.
Bibliography:Funding
This work was supported by Ministry of Science and Technology, NSTC112‐2320‐B‐038‐029, NSTC111‐2320‐B‐038‐038, Taipei Medical University, TMUCOM202101.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1520-4081
1522-7278
1522-7278
DOI:10.1002/tox.24436